Biostatistics Weekly Seminar

Using observational data to aggregate evidence of clinical efficacy with information on medical costs

Andrew Spieker PhD
Vanderbilt University Medical Center

Treatment cost and clinical effectiveness play large roles in helping shape health policy decisions. Owing to the impractical nature of randomized trials in many settings, cost-effectiveness analyses are often performed using data from observational studies and electronic medical records. Challenges such as censoring and confounding pose barriers to easy interpretation and must therefore be addressed. In this talk, we will present a causal framework to cost-effectiveness analysis, together with an easy-to-interpret visual tool for elucidating the proportion of people who can expect to benefit from an intervention at various willingness-to-pay thresholds. Finally, we discuss ways to handle time-dependent treatment and confounding, and the importance of doing so to make meaningful population-level policy decisions

2525 West End Ave., Large Biostatistics Conf. Rm.11105
30 January 2019

Speaker Itinerary

Topic revision: r3 - 20 Feb 2019, SrKrueger

This site is powered by FoswikiCopyright © 2013-2022 by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Vanderbilt Biostatistics Wiki? Send feedback